USPatent applicationPatented

Pesticidal 1-polyarylpyrazoles

Granted 19 Aug 2003 · 2 office actions

Current assignee: Rhone-Poulenc Inc. · originally Rhone-Poulenc Industries

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Scot Kevin Huber, Jamin Huang · Examiner: Fiona T. Powers · AU 1626 · TC 1600

Life of the application

9 dated events
⤢ drag to zoom20002005201020152020ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

A compound of formula (I): compositions containing them and methods of use to control pests.

Description

18 parts
›CROSS-REFERENCE TO RELATED APPLICATIONS · 1 of 4

This application is a divisional of U.S. patent application Ser. No. 09/832,861, filed Apr. 12, 2001, now U.S. Pat. No. 6,433,002, which is a divisional of U.S. patent application Ser. No. 09/606,185, filed Jun. 29, 2000, now U.S. Pat. No. 6,242,475, which is a divisional of U.S. patent application Ser. No. 09/216,878, filed Dec. 21, 1998, now U.S. Pat. No. 6,107,322, which is a divisional of U.S. patent application No. 08/963,631, filed Nov. 4, 1997, now U.S. Pat. No. 5,922,884, which claims the priority of U.S. Provisional Patent Application No. 60/030,128, filed Nov. 4, 1996. All five prior applications are incorporated by reference herein in their entireties and relied upon.

The invention relates to new 1-arylpyrazoles and derivatives thereof which have some valuable properties either as pesticides or as intermediates to make other pesticides. The invention further pertains to compositions of said compounds and methods, using said compounds either as intermediates to make other pesticides, or for the control of pests particularly insects, in particular to the application of said compounds or compositions in agricultural methods of use or for animal protection, particularly as pesticides, for controlling arthropods.

International Patent Publication No. WO 87/03781 and European Patent Publication No. 295117, 154115, 201852 describe insecticidal 1-(substituted phenyl) pyrazoles. Other prior art is also found in the text of these patent applications or the patents issued therefrom.

International Patent Publications No. WO 93/06089 and WO 94/21606 also describe insecticidal 1(4—SF 5 substituted phenyl) heterocycles which may be pyrroles as well as imidazoles or pyrazoles. The teaching of these patents is not substantially different from Iternational Patent Publication No. WO 87/03781 or from European Patent Publication No. 0295117 as far as pyrazoles are concerned.

It is an object of the present invention to provide new pesticidal compounds of the 1-arylpyrazole family together with processes for their preparation.

Another object of the present invention is to provide pesticidal compositions and pesticidal methods of use of the pesticidal pyrazole compounds against arthropods, especially insects, particularly in agricultural or horticultural crops, forestry, veterinary medicine or livestock husbandry, or in public health.

A third object of the present invention is to provide very active compounds with broad spectrum pesticidal activity, as well as compounds with selective special activity, e.g., aphicidal, miticidal, foliar insecticidal, soil insecticidal, systemic, antifeeding or pesticidal activity via seed treatment.

A fourth object of the present invention is to provide compounds with substantially enhanced and more rapid activity, especially against insects and more particularly insects in their larval stages.

A fifth objective of the present invention is to provide compounds with greatly improved (faster and greater) penetration into pest species when topically applied and to thus provide enhanced movement of the compounds to the pesticidal site(s) of action within the pest.

These and other objectives of the invention are met in whole or part and shall become readily apparent from the description of the present invention which follows.

The invention thus relates to compounds having the general formula (I):

wherein:

X is N or C—R 2 ;

Y is N or C—R 3 ;

W is N or C—R 4 ;

R 2 and R 3 are independently selected from H, halogen, hydroxy, alkyl, cycloalkyl, haloalkyl, alkoxy, haloalkoxy, CN, NO 2 , —S(O) n R 8 , alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, hydroxycarbonyl, aminosulfonyl, alkylaninosulfonyl, and dialkylaminosulfonyl;

R 4 is H, halogen, alkyl, alkoxy, CN, NO 2 , haloalkyl, haloalkoxy, thiocyanato, formyl, alkylcarbonyl, —CH═N—OH, —CH═N—O-alkyl, —S(NH 2 )(═NH), —S(O) n R 8 , mercapto, haloalkylcarbonyl, or a —S— radical so that two molecules are bound together to form a disulfide compound;

R 5 is hydrogen, halogen, —NR 9 R 10 , —N═CR 11 R 19 , —S(O) n R 8 , formyl, alkylcarbonyl, haloalkylcarbonyl, cyano, alkyl, haloalkyl, hydrazino, alkoxycarbonyl, alkylthiocarbonyl, 1H-pyrrol-1-yl or 1H-pyrazol-1-yl;

R 8 is alkyl or haloalkyl, alkenyl or alkynyl, or a cycloalkyl ring containing 3 to 5 carbon atoms;

R 11 is H, or alkyl;

R 19 may also be hydrogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, amino, monoalkylamino, dialkylamino, or R 19 is phenyl, thienyl, pyridyl or furyl, each of which is unsubstituted or substituted with alkyl, haloalkyl, halogen, NO 2 , CN, alkoxy, haloalkoxy, OH, alkylcarbonyl, alkylcarbonyloxy;

R 9 and R 10 independent of one another, are H, alkyl, haloalkyl, alkylcarbonyl, haloalkylcarbonyl, R 8 S(O) n , formyl, alkenyl, alkynyl, alkoxycarbonyl, alkylthiocarbonyl, aroyl; or are joined so as together form a divalent radical having 4 to 6 atoms in the chain, this divalent radical being alkylene, alkyleneoxyalkylene or alkyleneaminoalkylene, preferably to form a morpholine, pyrrolidine, piperidine or piperazine ring; the alkyl portion of R 9 and R 10 may be substituted by R 7 ;

R 7 is cyano, nitro, alkoxy, haloalkoxy, R 8 S(O) n , —C(O)alkyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, —CO 2 H, halogen, hydroxy, aminosulfonyl, alkylaminosulfonyl or dialkylaminosulfonyl;

Z is N or C—R 16 ;

n is zero, one or two;

R 12 , R 13 , R 15 , R 16 , are independently selected from hydrogen, halogen, alkyl, haloalkyl, cyanoalkyl, cyano, nitro, amino, hydrazino, alkoxy, haloalkoxy, alkylsulfenyl, alkylsulfinyl, alkylsulfonyl, haloalkylsulfenyl, haloalkylsulfinyl, haloalkylsulfonyl, formyl, alkylcarbonyl, alkoxycarbonyl;

R 22 , R 23 ,R 24 , R 25 , R 26 are hydrogen, halogen, alkyl, haloalkyl, cyanoalkyl, cyano, nitro, amino, hydrazino, alkoxy, haloalkoxy, haloalkylcarbonyl, formyl, alkylcarbonyl, thioamide, amide, and alkoxycarbonyl, SF 5 , R 8 S(O) n ; preferably R 24 is halogen, haloalkyl or haloalkoxy; or R 22 and R 23 or R 23 and R 24 or R 25 and R 26 may also be together a divinylidene group (—CH═CH—CH═CH—) or a methylene diether (—O—CH 2 —O—) or halomethylene diether (—O—CF 2 —O—) so as to form a cyclic ring vicinal to the phenyl ring; or pesticidally acceptable salts thereof.

›CROSS-REFERENCE TO RELATED APPLICATIONS · 2 of 4

By the term “pesticidally acceptable salts” is meant salts the anions and cations of which are known and accepted in the art for the formation of pesticidally acceptable salts. Preferably such salts are water soluble. Suitable acid addition salts formed from compounds of formula (I) containing an amine group, include salts with inorganic acids for example hydrochlorides, phosphates, sulfates and nitrates, and salts with organic acids for example acetates. Suitable salts with bases formed from compounds of formula (I) containing a suitably acidic group include alkali metal (for example sodium or potassium) salts, ammonium salts and organic amine (for example diethanolamine or morpholine) salts.

In the present invention, some words are used in a specific sense:

The term “lower alkyl—S(O) n ” means a radical of the formula —S(O) n — lower alkyl. The term “R 10 S(O) n ” means a radical of the formula —S(O) n R 10 . The term “aminocarbonyl” means a carbamoyl radical, that is, a radical of the formula —C(O)NH 2 . Similarly, the term “alkylaminocarbonyl” means an alkylcarbamoyl radical, that is, a radical of the formula —C(O)—NH-alkyl; and the term “dialkylaminocarbonyl” means a dialkylcarbamoyl radical, that is, a radical of the formula —C(O)—N(alkyl) 2 in which the alkyl moieties can be the same or different. The term “aminosulfonyl” means a sulfamoyl radical, that is, —SO 2 NH 2 . Similarly, the term “alkylaminosulfonyl” means an alkylsulfamoyl radical, that is, a radical of the formula —SO 2 NH-alkyl; while the term “dialkylaminosulfonyl” means a dialkylsulfamoyl radical, which has the formula —SO 2 N(alkyl) 2 wherein the alkyl moieties can be the same or different.

The term “halo” before the name of a radical means that this radical is partially or completely halogenated, that is to say, substituted by F, Cl, Br, or I, in any combination, preferably by F or Cl. The term “halogen” means F, Cl, Br or I. The term “lower” before the name of a radical having a carbon skeleton means that this carbon skeleton has less than 6 carbon atoms. When the name of any substituent is repeated, it keeps the same meaning unless otherwise specified. The term “aryl” designates a carbon and/or heteroatom-containing aromatic radical which is preferably phenyl optionally substituted with one or more substituents selected from halogen, methyl and methoxy, especially phenyl, halophenyl, tolyl or xylyl. The term “aroyl” designates a carbonyl aromatic radical, that is, aryl—C(O)—, which is preferably a benzoyl, methylbenzoyl, halobenzoyl or xylylcarbonyl radical. The term “acyl” designates an alkylcarbonyl radical. The various individual radicals (such as alkyl, alkenyl, alkynyl, alkoxy and alkylene or the like) generally contain up to six carbon atoms.

A preferred class of compounds of formula (I) is that wherein

X is N;

Y is C—R 3 ;

W is C—R 4 ;

R 3 is H, halogen, hydroxy, alkyl, cycloalkyl, haloalkyl, alkoxy, haloalkoxy, CN, NO 2 , —S(O) n R 8 , alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, hydroxycarbonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl;

R 4 is H, halogen, alkyl, alkoxy, CN, NO 2 , haloalkyl, haloalkoxy, thiocyanato, formyl, alkylcarbonyl, —CH═N—OH, —CH═N—O-alkyl, —S(NH 2 )(═NH), —S(O) n R 8 , mercapto, haloalkylcarbonyl, or a —S— radical so that two molecules are bound together to form a disufide compound;

R 5 is hydrogen, halogen, —NR 9 R 10 , —N═CR 11 R 19 , —S(O) n R 8 , formyl, alkylcarbonyl, haloalkylcarbonyl, cyano, lower alkyl, hydrazino, alkoxycarbonyl, alkylthiocarbonyl, 1H-pyrrol-1-yl or 1H-pyrazol-1-yl, preferably, amino —NR 9 R 10 ;

R 8 is alkyl or haloalkyl, alkenyl or alkynyl; or a cycloalkyl ring containing 3 to 5 carbon atoms; preferably R 8 is lower alkyl;

R 11 is H or alkyl;

R 19 may also be hydrogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, amino, monoalkylamino, dialkylamino;

or R 19 is phenyl, thienyl, pyridyl or furyl, all of them being optionally substituted with alkyl, haloalkyl, halogen, NO 2 , CN, alkoxy, haloalkoxy, OH, alkylcarbonyl, alkylcarbonyloxy;

R 9 and R 10 are H, alkyl, haloalkyl, alkylcarbonyl, haloalkylcarbonyl, R 8 —S(O) n , formyl, alkenyl, alkynyl, alkoxycarbonyl, alkylthiocarbonyl, aroyl; or are joined so as together form a divalent radical having 4 to 6 atoms in the chain, this divalent radical being alkylene, alkyleneoxyalkylene or alkyleneaminoalkylene, preferably to form a morpholine, pyrrolidine, piperidine or piperazine ring; the alkyl portion of R 9 and R 10 may be substituted by R 7 ;

R 7 is cyano, nitro, alkoxy, haloalkoxy, R 8 S(O) n , —C(O)alkyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, —CO 2 H, halogen, hydroxy, aminosulfonyl, alkylaminosulfonyl or dialkylaminosulfonyl;

Z is N or C—R 16 ;

n is zero, one or two;

R 12 , R 13 , R 15 , R 16 , are separately hydrogen, halogen, alkyl, haloalkyl, cyanoalkyl, cyano, nitro, amino, hydrazino, alkoxy, haloalkoxy, alkylsulfenyl, alkylsulfinyl, alkylsulfonyl, haloalkylsulfenyl, haloalkylsulfinyl, haloalkylsulfonyl, formyl, alkylcarbonyl, alkoxycarbonyl;

R 22 , R 23 , R 24 , R 25 , R 26 are hydrogen, halogen, alkyl, haloalkyl, cyanoalkyl, cyano, nitro, amino, hydrazino, alkoxy, haloalkoxy, haloalkylcarbonyl, formyl, alkylcarbonyl, thioamide, amide, and alkoxycarbonyl, SF 5 , R 8 S(O) n , preferably, R 24 is halogen, haloalkyl or haloalkoxy; or R 22 and R 23 or R 23 and R 24 or R 25 and R 26 may also be together a divinylidene group (—CH═CH—CH═CH—) or a methylene diether (—O—CH 2 —O—) or halomethylene diether (—O—CF 2 —O—) so as to form a cyclic ring vicinal to the phenyl ring; or a pesticidally acceptable salt thereof.

Another preferred class of the compounds of formula (I) are those with one or more of the following features wherein:

X is N or C—R 2 ;

Y is N or C—R 3 ;

W is N or C—R 4 ;

R 3 is CN or halogen;

R 4 is H, halogen, formyl, or —S(O) n R 8 ;

R 5 is hydrogen, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, or —NR 9 R 10 ;

R 8 is methyl, ethyl, —CF 3 , —CFCl 2 , —CF 2 Cl;

›CROSS-REFERENCE TO RELATED APPLICATIONS · 3 of 4

R 12 and R 16 are independently selected from F, Cl, Br and H;

R 13 and R 15 are H;

R 24 is —CF 3 , —OCF 3 , —CHF 2 , —S(O) n CF 3 , —CFCl 2 , —CF 2 Cl, —OCF 2 Cl, —OCFCl 2 , Cl, Br or F; or

Z is CCl, CF, CBr or N.

A further especially preferred class of compounds are those wherein:

X is N;

Y is C—R 3 ;

W is C—R 4 ;

R 12 and R 16 are Cl or Br;

R 13 and R 15 are H;

R 24 is —CF 3 , —OCF 3 or Br;

R 5 is amino;

R 9 and R 10 are H, alkyl or alkylcarbonyl;

R 8 is methyl or ethyl or CF 3 , CCl 2 F, CClF 2 ; and

R 3 is CN or halogen.

For the above preferred compounds, there are optimum combinations of substituent groups.

Further, preferred S(O) n R 8 substituents in formula (I) are: methylthio, methylsulfinyl, methylsulfonyl, ethylsulfinyl, ethylsulfonyl, ethylthio, cyclopropylsulfinyl, cyclopropylthio, cyclopropylsulfonyl, isopropylsulfinyl, isopropylsulfonyl, isopropylthio, trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, dichlorofluoromethylthio, dichloromethylsulfinyl, dichloromethylsulfonyl, chlorodifluoromethylthio, chlorodifluoromethylsulfonyl or chlorodifluoromethylsulfinyl.

Some compounds are useful as intermediates to make other pesticides, others are useful directly as pesticides. Compounds wherein R 23 or R 24 or R 25 is formyl are preferred as intermediates as well as compounds wherein R 5 is H or compounds wherein simultaneously R 4 is not halogenated and R 22 and R 23 and R 24 and R 25 and R 26 are H.

The compounds of general formula (I) can be prepared by the application or adaptation of known methods (i.e., methods heretofore used or described in the chemical literature including the Chemical Abstracts ) employing as starting material the compounds of formula (II)

wherein the various substituents have the same meaning as in formula (I) and halo is a halogen atom, preferably bromine or iodine.

The compounds of formula (II) can be prepared by methods or processes similar to those described in International patent applications WO 87/03781, 93/06089, 94/21606, in European patent applications 295117, 403300, 385809, 500209, 679650, 285,893, and 780,381, U.S. Pat. Nos. 5,232,940, 5,236,938, 5,187,185, 5,223,525 and German Patent application 19511269 or by other methods known to the skilled addressee. The skilled addressee understands and is generally knowledgeable of Chemical Abstracts.

According to a first method of preparation of compounds of formula (I) from compounds of formula (II), a compound of formula (II) is caused to react with a boric acid or ester, preferably in presence of a coupling catalyst, so as to form a compound of formula (III)

wherein the substituents have the same meaning as previously indicated, and B(OR 30 ) 2 represents a boric acid or ester group (R 30 is preferably hydrogen, alkyl, or a divalent lower alkylene radical such that two R 30 O radicals may form a cyclic borate ester),

said compound (III) being, in a second step, caused to react with a compound of formula (VI)

wherein R 20 is bromine or iodine or O—SO 2 CF 3 .

The first step of this first process is generally and preferably conducted in an organic solvent, for example an hydrocarbon such as toluene or xylene; an amide such as dimethylformamide or N-methylpyrrolidone; an ether such as tetrahydrofuran, dimethoxyethane or 2-methoxyethylether; the temperature is generally between 50° C. and 150° C.; utilizing as catalysts organic derivatives of palladium including palladium acetate, tetrakis (triphenylphosphine) palladium(O) or Pd 2 (dibenzylidene acetone) 3 , generally in the presence of a base such as an alkaline hydroxide or carbonate acetate ion or an amine. The boron derivative used as a reactant with the compound of formula (II) is preferably a cyclic diboron ester or acid of formula (R 30 O) 2 B—B(OR 30 ) 2 .

The second step of this first process is advantageously conducted in an organic solvent, for example an hydrocarbon such as toluene or xylene; an amide such as dimethylformamide or N-methylpyrrolidone; an ether such as tetrahydrofuran, dimethoxyethane or 2-methoxyethylether; the temperature is generally between 50° C. and 150° C.; utilizing as catalysts organic derivatives of palladium including palladium acetate, tetrakis(triphenylphosphine)palladium(O) or Pd 2 (dibenzylidene acetone) 3 , generally in the presence of a base such as an alkaline hydroxide or carbonate acetate ion or an amine.

According to another method of preparation of compound of formula (I), a compound of formula (II) is caused to react with a compound of formula (IV):

wherein the substituents have the same meaning as previously indicated.

The process is generally and preferably conducted in an organic solvent, for example an hydrocarbon such as toluene or xylene; an amide such as dimethylformamide or N-methylpyrrolidone; an ether such as tetrahydrofuran, dimethoxyethane or 2-methoxyethylether; the temperature is generally between 50° C. and 150° C.; utilizing as catalysts organic derivatives of palladium including palladium acetate, tetrakis(triphenylphosphine)palladium(O) or Pd 2 (dibenzylidene acetone) 3 , generally in the presence of a base such as an alkaline hydroxide or carbonate acetate ion or an amine.

According to still another method of preparation of compound of formula (I), a compound of formula (II) is caused to react in the presence of a catalyst as described above, with a hexaalkylstannane [(alkyl or cycloalkyl) 3 Sn] 2 so as to form a compound of formula (V):

which in a second step is caused to react with a compound of formula (IV) in the presence of a coupling catalyst.

The first step of the process is generally conducted in an organic solvent, for example an hydrocarbon such as toluene or xylene; an amide such as dimethylformamide or N-methylpyrrolidone; an ether such as tetrahydrofuran, dimethoxyethane or 2-methoxyethylether, at a temperature generally between 50° C. and 150° C.; utilizing as catalysts organic derivatives of palladium including palladium acetate, tetrakis(triphenylphosphine)palladium(O) or Pd 2 (dibenzylidene acetone) 3 .

›CROSS-REFERENCE TO RELATED APPLICATIONS · 4 of 4

The second step of this second process is generally conducted in an organic solvent, for example an hydrocarbon such as toluene or xylene; an amide such as dimethylformamide or N-methylpyrrolidone; an ether such as tetrahydrofuran, dimethoxyethane or 2-methoxyethylether; the temperature is generally between 50° C. and 150° C.; as catalysts, organic derivatives of palladium such as Pd (P-phenyl 3 ) 4 , Pd 2 (dibenzylidene acetone) 3 , Pd (O—CO—CH 3 ) 2 may be cited.

According to still another method of preparation of compound of formula (I), a compound of formula (II) is caused to react with a compound of formula (VII)

preferably in the presence of a coupling catalyst as described above, and preferably in a solvent as described above, and preferably at a temperature from 50° C. to 150° C.

According to another method of preparation of a compound of formula (I), a compound of formula (VIII):

is reacted in a step to form a pyrrole, imidazole, triazole, or pyrazole of formula (I). Such reactions are known and can be found in Katritzky, Rees, and Scriven, Comprehensive Heterocyclic Chemistry II, volumes 2.3.4 1996, Pergamon Press, London.

The invention is illustrated by the following examples, which are not considered as limiting the invention but are given to better enable use of it.

›Examples7
›EXAMPLE 1

Preparation of 1-[2,6-dichloro-4-(4-trifluoromethylphenyl)phenyl]-3-cyano-4-trifluoromethylthio-5-aminopyrazole

A mixture of 6 g of 5-amino-3-cyano-1-(2,6-dichloro-4-bromophenyl)-4-trifluoromethylthiopyrazole (prepared according to procedures reported in U.S. Pat. No. 5,232,940), 4-trifuoromethylphenylboronic acid (5.3 g), K 2 CO 3 (5.8 g), tris-(dibenzylidene acetone) dipalladium (0.6 g) and diglyme was heated at 130° C. for 25 hours. After cooling to 20° C., the mixture was poured into water and extracted with diethyl ether. The ether solutions were combined, dried, filtered and the filtrate concentrated and purified by chromatography. The desired product as a solid (3.9 g, mp 181-184° C.) was obtained.

›EXAMPLE 2

Preparation of 1-[2,6-dichloro-4-(4trifluoromethylphenyl)phenyl]-3-cyano-4-trifluoromethylsulfonyl-5-aminopyrazole

A solution of 1-[2,6dichloro-4-(trifluoromethylphenyl)phenyl]-3-cyano-4-trifluoromethylthio-5-aminopyrazole (0.5 g), m-chloroperbenzoic acid (2.2 g) and 1,2-dichloro-ethane was heated at reflux for 40 hours. After cooling to 20° C., the mixture was dissolved in diethyl ether and washed with sat, aqueous NaHCO 3 solution twice, then saturated aqueous NaHSO 3 solution twice, dried, filtered, and the filtrate concentrated and purified by chromatography. The desired product as a solid (0.13 g, mp 197-202° C.) was obtained.

›EXAMPLE 3

Preparation of 1-[2,6dichloro-4-(tributyltin)phenyl]-3-cyano-4-trifluoromethylthio-5-aminopyrazole

A mixture of 1-(2,6-dichloro4-bromophenyl)-3-cyano-4-trifluoromethylthio-5-aminopyrazole (5 g), bis-(tributyltin) (6.7 g), tetrakis(tri-phenylphosphine)palladium (O) (1.3 g) and 1-methyl-2-pyrrolidinone was heated to reflux for 75 minutes, cooled to 20° C., poured to water and extracted with methyl t-butyl ether. After concentrattion to dryness, methylene chloride was added and stirred with saturated aqueous KF solution for 16 hours. More water was added and extracted with methylene chloride. The methylene chloride solutions were combined, dried, filtered and the filtrate concentrated and purified via chromatography. The desired product as a solid (1.9 g, mp 116-117° C.) was obtained.

›EXAMPLE 4

Preparation of 1-[2,6-dichloro4-(2,3,5,6-tetrafluoropyrid4-yl)phenyl]-3-cyano-4-trifluoromethylthio-5-aminopyrazole

A mixture of 1-[2,6-dichloro-4-(tributyltin)phenyl]-3-cyano-4-trifluoromethylthio-5-aminopyrazole (0.5 g), 4-bromo-2,3,5,6-tetrafluoropyridine (0.1 mL), tetrakis(tri-phenylphosphine) palladium (O) (0.1 g) and THF was refluxed for 26 hours. After cooling to 20° C., methylene chloride was added and stirred with saturated aqueous KF solution for 16 hours. The mixture was filtered with diethyl ether and dried, filtered again and the filtrate concentrated and purified via chromatography. The desired product as a solid (87 mg, mp 100-104° C.) was obtained.

›EXAMPLE 5

Preparation of 1-[2,6-dichloro-4-(4trifluoromethylphenyl)phenyl]-3-cyano-5-aminopyrazole.

A mixture of 1-(2,6-dichloro-4-bromophenyl)-3-cyano-5-aminopyrazole (45 g, prepared according to procedures reported in U.S. Pat. No. 5,232,940), 4-trifluoromethylphenylboronic acid (45 g), 2 M of Na 2 CO 3 (75 mL), tris-(dibenzylideneacetone) dipalladium (6.4 g), toluene and ethanol was heated at 130° C. for 25 hours. After cooling to 20° C., the mixture was poured into water and extracted with diethyl ether. The ether solutions were combined, dried, filtered and the filtrate concentrated and purified via chromatography. The desired product as a solid (30.6 g, mp 195-199° C.) was obtained.

›EXAMPLE 6

Preparation of 1-[2,6-dichloro-4-(4-trifluoromethylphenyl)phenyl]-3-cyano4-bromo-5-aminopyrazole.

A mixture of 1-[2,6-dichloro-4-(4-trifluoromethylphenyl)phenyl]-3-cyano-5-aminopyrazole (1 g), N-bromosuccinimide (0.5 g) and acetonitrile was stirred at 20° C. for 90 minutes, then concentrated and the residue was mixed with diethyl ether, washed with saturated aqueous NaHCO 3 solution, dried, filtered and the filtrate concentrated and purified via chromatography. The desired product as a solid (1.04 g, mp 178-180° C.) was obtained.

›EXAMPLE 7

Preparation of 4-dichlorofluoromethylsulfenyl-1-[2-fluoro-4-(4-trifluoromethylphenyl) phenyl]imidazole

›Step A

A solution of 4-bromo-2-fluoroaniline (3.8 g) in 20 ml of triethyl orthoformate was stirred at room temperature. After stirring for 1 h, tetrahydrofuran (40 ml), aminoacetonitrile hydrochloride (2.8 g), and diisopropylamine (5.3 ml) were added and stirring continued for an additional hour. After 1 h, the mixture was poured into 150 ml of ice water and extracted with 150 ml of dichloromethane. The organic solution was washed twice with water and dried over magnesium sulfate. Evaporation of solvents afforded a light purple solid (3.1 g), which was washed with hexane and filtered.

The solid was dissolved in 40 ml of dichloromethane at reflux, cooled to room temperature, and treated with tetramethylguanidine (1.6 ml), added dropwise over twenty minutes. After stirring at room temperature overnight, the mixture was cooled in an ice/salt bath and dichlorofluoromethylsulfenyl chloride (1.5 ml) was added. After 1 h, the mixture was diluted with 100 ml of methylene chloride and washed with saturated sodium bicarbonate solution, then with water, then dried over magnesium sulfate. After filtration and evaporation, chromatography on silica gel afforded 5-amino-4-dichlorofluoromethylsulfenyl-1-(2-fluoro-4-bromophenyl)imidazole (1.285 g).

›Step B

1 g of 5-amino-4-dichlorofluoromethylsulfenyl-1-(2-fluoro-4-bromophenyl) imidazole was dissolved in 15 ml of tetrahydrofuran, cooled to 0° C., and treated with t-butylnitrite. After 1 h, the mixture is evaporated. Silca gel chromatography afforded 4-dichlorofluoromethylsulfenyl-1-(2-fluoro-4-bromophenyl)imidazole (0.555 g).

›Step C · 1 of 3

50 mg of 4-dichlorofluoromethylsulfenyl-1-(2-fluoro-4-bromophenyl)imidazole and 37 mg of trifluoromethylphenylboronic acid in 3 ml of toluene were treated with 0.13 ml of 2 M aqueous potassium carbonate and a catalytic amount (about 5 mg) of palladium tetrakis(triphenylphosphine). The mixture was heated at 90° C. for 12 h, then cooled to room temperature and evaporated. Silica gel chromatography afforded 4-dichlorofluoromethylsulfenyl-1-[2-fluoro-4-(4-trifluoromethylphenyl)phenyl]imidazole (27.3 mg, mass spec m/e 438).

In a manner similar to that employed in examples 1 to 7, the following compounds in Tables 1-4 were also prepared. The last column of the table indicates the physical characteristic of the compound obtained from the mass spectrum analysis. It is the m/e value from the mass spectrum of the molecular ion. The number of the compound is for identification only.

N/A=Not Applicable

AroCH is [4—OH 3-methoxy phenyl]—CH, so that AroCH═N— is the group [4—OH 3-methoxy phenyl]—CH═N—

The present invention provides also a method for controlling pests at a locus comprising applying to said locus a pesticidally effective amount of a compound of formula (I), or a pesticidal composition comprising a pesticidally effective amount of a compound of formula (I) and a pesticidally acceptable carrier therefor. In a preferred embodiment, the invention provides a method for controlling insects at a locus comprising applying to said locus an insecticidally effective amount of a compound of formula (I), or an insecticidally effective amount of an insecticidal composition comprising an insecticidally effective amount of a compound of formula (I) and an agriculturally acceptable inert carrier therefor. Preferably, the locus to which the pesticidally (especially insecticidally) effective amount is applied is a crop-growing area, that is, an area in which a crop is growing or in which a crop has been planted, or an area in which a crop will be planted/grown.

The compositions which can be used in the invention for the pesticidal/insecticidal treatment of the invention can comprise from about 0.001 to 95% of the compound of formula (I).

The diluted liquid formulations, as applied to the locus to be treated or crop, generally comprise from about 0.001 to about 3% of active ingredient of formula (I), preferably from about 0.1 to about 0.5%.

The solid formulations as applied to the locus or crop generally comprise from about 0.1 to about 8% of active ingredient of formula (I), preferably from about 0.5 to about 1.5%.

The concentrated compositions are the compositions which are commercialized or transported or stored. For application to plants, they are normally diluted in water and applied in such diluted form. The diluted forms are part of the invention as well as the concentrated forms.

The concentrated formulations generally comprise from about 5 to about 95% of active ingredient of formula (I), preferably from about 10 to about 50%.

The insecticidal compositions of the invention can be applied once, or more than once, throughout the whole insect season. Insecticidal compositions according to the invention are usually applied to the locus to be treated or crop area at a rate of from about 0.01 to about 2 kg/ha of active ingredient, preferably from about 0.1 to about 1 kg/ha.

The concentrated insecticidal compositions according to the invention can be in the form of a solid, e.g., dusts or granules or wettable powders, or, preferably, in the form of a liquid, such as an emulsifiable concentrate or a true solution.

The compositions according to the instant invention generally comprise from about 0.5 to about 95% of active ingredient of formula (I). The remainder of the composition up to 100% comprises a carrier as well as various additives such as those hereafter indicated.

By “carrier”, there is meant herein an organic or inorganic material, which can be natural or synthetic, and which is associated with the active ingredient and which facilitates its application to the locus to be treated or crop. This carrier is thus generally inert and should be agriculturally acceptable, especially on the contemplated or treated locus or crop. The carrier can be solid (clay, silicates, silica, resins, wax, fertilizers, etc.) or liquid (water, alcohols, ketones, oil solvents, saturated or unsaturated hydrocarbons, chlorinated hydrocarbons, liquified petroleum gas, etc.).

Among the many additives, the compositions of the invention can comprise surfactants as well as other ingredients such as dispersants, stickers, antifoam agents, antifreezing agents, dyestuffs, thickeners, adhesives, protective colloids, penetrating agents, stabilizing agents, sequestering agents, antiflocculating agents, corrosion inhibitors, pigments and polymers.

More generally, the compositions of the invention can comprise all kinds of solid or liquid additives which are known in the art of insecticides and insecticidal treatments.

The surfactants can be of the emulsifying or wetting type, ionic or non-ionic. Possible surfactants are salts of polyacrylic or lignosulfonic acids; salts of phenolsulfonic or naphthalenesulfonic acids; polycondensates of ethylene oxide with fatty alcohols or fatty acids or fatty amines or substituted phenols (particularly alkylphenols or arylphenols); ester-salts of sulfosuccinic acids; taurine derivatives, such as alkyl taurates; phosphoric esters; or esters of alcohols or polyoxyethylated phenols. When the spraying vehicle is water, the use of at least one surfactant is generally required because the active ingredients are not water-soluble.

The method of application of the compositions of the invention is generally the spraying of a mixture which has been previously made, by dilution of more concentrated formulations according to the invention.

Solid compositions can be powders for dusting or for dispersion (wherein the content of active ingredient can be up to 100%) and granules, especially extruded or compacted granules, or granules which have been made by impregnation of a powder (the content of active ingredient in such powders being between about 1 and about 80%).

›Step C · 2 of 3

Liquid compositions or compositions which have to be liquid when applied include solutions, water-soluble concentrates, emulsifiable concentrates, emulsions, wettable powders or pastes or water-dispersible granules.

Emulsifiable concentrates generally comprise from about 10 to about 80% of active ingredient; the emulsions when applied generally comprise from about 0.01 to about 20% of active ingredient.

For example, the emulsifiable concentrates can comprise the solvent and, to the extent needed, from about 2 to about 20% of suitable additives such as stabilizers, surfactants, penetrating agents, corrosion inhibitors or other additives already recited.

These concentrates are usually diluted in tank water so as to obtain the dilution appropriate for spraying.

The concentrated suspensions can also be applied by spraying and have to be fluid without allowing any solid to separate and fall to the bottom. Generally they comprise from about 1 to about 75% of active ingredient (preferably from about 2 to about 50%), from about 0.5 to about 15% of surfactant, from about 0.1 to about 10% of thickener, from 0 to about 10% of other suitable additives as already indicated, the remainder being water or an organic liquid wherein the active ingredient is insoluble or has a low solubility.

The wettable powders generally comprise the active ingredient (from about 1 to about 95%, preferably from about 2 to about 80%), the solid carrier, a wetting agent (from 0 to about 5%), a dispersing agent (from about 3 to about 10%) and, to the extent needed, from 0 to about 10% of other additives such as stabilizers and others as already listed.

In order to obtain these wettable powders or dusting powders, it is appropriate to intimately mix the active ingredients and the additives, as by grinding in a mill or similar device.

Dispersible granules are generally made by agglomeration of a powder, followed by an appropriate granulation process.

The emulsions herein described can be of the oil-in-water or water-in-oil types. Fluidity of the emulsions can range from low viscosities up to high viscosities approaching those of gels.

Among these many compositions or formulations, one skilled in the art can choose the one most appropriate, according to the specific conditions of the treatment problem.

The compounds and compositions of the invention can also be used in admixtures with another pesticide, e.g., an insecticide, acaricide or herbicide.

The compounds of the invention may also be used in controlling pests found in non-agricultural domains.

In the field of veterinary medicine or livestock husbandry or in the maintenance of public health against arthropods, helminths or protozoa which are parasitic internally or externally upon vertebrates, particularly warm-blooded vertebrates, for example man or domestic animals, e.g. cattle, sheep, goats, equines, swine, poultry, dogs or cats, for example Acarina, including ticks (e.g. Ixodes spp., Boolphilus spp. e.g. Boophilus microplus , Amblyomma spp., Hyalomma spp., Rhipicephalus spp. e.g. Rhipiceghalus appendiculatus , Haemaphysalis spp., Dermacentor spp., Ornithodorus spp. (e.g. Ornithodorus moubata ) and mites (e.g. Damalinia spp., Dermahyssus gallinae , Sarcoptes spp. e.g. Sarcoptes scabiei , Psoroptes spp., Chorioptes spp;, Demodex spp., Eutrombicula spp.,); Diptera (e.g. Aedes spp., Anopheles spp., Dermatobia spp., Haematobia spp., Musca spp., Hippoboscidae spp., Hypoderma spp., Gasterophilus spp., Simulium spp); Stomoxys spp., Hemiptera (e.g. Triatoma spp); Phthirapter (e.g. Damalinia spp., Linognathus spp.); Siphonaptera (e.g. Ctenocephalides spp.); Dictyootera (e.g. Periplaneta spp., Blatella spp.); Hymenoptera (e.g. Monomorium pharaonis ); for example against infections of the gastro-intestinal tract caused by parasitic nematode worms, for example members of the family Trichostrongylidae, Nippostrongylus brasiliensis, Trichinella spiralis, Haemonchus contortus, Trichostrongylus colubriformis, Nematodirus batus, Ostertagis circumcincta, Trichostrongylus axei , Cooperia spp. and Hymenolepis nana ; in the control and treatment of protozoal diseases caused by, for example, Eimeria spp. e.g. Eimeria tenella, Eimeria acervulina, Eimeria brunetti, Eimeria maxima and Eimeria necatrix, Trypanosoms cruzi , Leishaminia spp., Plasmodium spp., Babesis spp., Trichomonadidae spp., Histomanas spp., Giardia spp., Toxoplasma spp., Entamoeba histolytica and Theileria spp.

Furthermore the compounds of the invention may be useful for coccidiosis, a disease caused by infections from protozoan parasites of the genus Eimeria.

Compositions

Solid or liquid compositions for application topically to animals, timber, stored products or household goods usually contain from about 0.00005% to about 90%, more particularly from about 0.001% to about 10%, by weight of one or more compounds of general formula (I). For administration to animals orally or parenterally, including percutaneously solid or liquid compositions, these normally contain from about 0.1% to about 90% by weight of one or more compounds of general formula (I). Medicated feedstuffs normally contain from about 0.001% to about 3% by weight of one or more compounds of general formula (I). Concentrates or supplements for mixing with feedstuffs normally contain from about 5% to about 90%, preferably from about 5% to about 50%, by weight of one or more compounds of general formula(I). Mineral salt licks normally contain from about 0.1% to about 10% by weight of one or more compounds of general formula (I).

Dusts or liquid compositions for application to livestock, persons, goods, premises or outdoor areas may contain from about 0.0001% to about 15%, more especially from about 0.005% to about 2.0%, by weight, of one or more compounds of general formula (I). Suitable concentrations in treated waters are between about 0.0001 ppm and about 20 ppm, more particularly about 0.001 ppm to about 5.0 ppm of one or more compounds of general formula (I) and may be used therapeutically in fish farming with appropriate exposure times. Edible baits may contain from about 0.01% to about 5%, preferably from about 0.01% to about 1.0%, by weight, of one or more compounds of general formula (I).

›Step C · 3 of 3

When administered to vertebrates parenterally, orally or by percutaneous or other means, the dosage of compounds of general formula (I) will depend upon the species, age, or health of the vertebrate and upon the nature and degree of its actual or potential infestation by arthropod, hehminth or protozoan pests. A single dose of about 0.1 to about 100 mg, preferably about 2.0 to about 20.0 mg, per kg body weight of the animal or doses of about 0.01 to about 20.0 mg, preferably about 0.1 to about 5.0 mg, per kg body weight of the animal per day, for sustained medication, are generally suitable by oral or parenteral administration. By use of sustained release formulations or devices, the daily doses required over a period of months may be combined and administered to animals on a single occasion.

The following methods were used to apply the compounds of the invention and to observe the results obtained therewith: a foliar/contact spray on sucking (aphids) or chewing (Lepidoptera) insects.

The species tested were as follows:

GENUS, SPECIES
›COMMON NAME

Aphis gossypii

cotton leaf aphid

Musca domestica

housefly

Diabrotica virgifera

Western cornrootworm

Periplaneta americana

American Cockroaches

Spodoptera eridania

Southern armyworm

The Housefly Bait/Contact Test

About 25 four to six-day-old adult houseflies were anesthetized and placed in a cage with a sugar water bait solution containing the compound. The concentration of the selected compound of formula (I) in the bait solution was 50 ppm. After 24 hours, flies which showed no movement on stimulation were considered dead.

Foliar Application (Contact Test) With Aphids

Aphid-infested cotton plants were placed on a revolving turntable, and sprayed to runoff with a 100 ppm formulation of the selected compound of formula (I). The treated, A. gossypii -infested plants were held for three days after treatment, after which the dead aphids were counted.

Application on Western Cornrootworm

Jars are filled with 60 g dry soil homogeneously mixed with 5 ml aqueous solution containing the compound to be tested. After drying, four germinated corn seedlings are placed in the bottom of each jar and the soil is wetted. Then ten newly born larvae are placed in each jar. The jars are stored for six days at 27° C. under 70% of relative humidity. The number of surviving larvae are then counted.

Application by Contact to Cockroaches

The inner wall of a 100 ml jar is covered by shaking 2 ml of pesticidal formulation. Furthermore, a pellet of dog chow is placed into a jar and the pesticidal formulation is absorbed on the pellet, using excess liquid. The jar is then left open up to evaporation of liquid. Cockroach nymphs are placed in the jar and mortality is assessed after five days.

Application to Southern Armyworm

Leaves of soybeans were sprayed to run-off with a spray of various concentrations. Then the leaves were allowed to dry, excised, and placed into a container with five larvae. The containers are stored for five days at 25° C. under 50% relative humidity. Mortality ratings are then counted.

Application to Caenorhabditis Elegans (Nematode Worm)

This test is significative for animal health applications of active ingredient.

Test formulation are prepared by mixing 2 microliters of dimethylsulfoxide with 100 microliters of a solution of Escherichia Coli (which is food for C. elegans ). 98 microliters of this mixture are then mixed with an inoculum solution which consists of mixed life stages of C. Elegans (about 50 worms). This new mixture is stored 7 days at 20° C. Mortality is then visually assessed as well as the behavior of the worm. For the mortality, the rating is either 1 (large increase in number of the population, similar to the control which is trebbling in 7 days) or 3 (slight increase of the population, but significantly less increase than the control) or 5 (little to no increase in the population). For the behavior effect, the rating is either 1 (normal motion) or 3 (motion is slower than the control) or 5 (little to no movement).

All the hereinabove prepared compounds show a positive activity in one or more of these tests (rather good activity on C. elegans ).

While the invention has been described in terms of various preferred embodiments, the person skilled in the art will appreciate that various modifications, substitutions, omissions and changes can be made without departing from the spirit thereof. Accordingly, it is intended that the scope of the present invention be limited solely by the scope of the following claims, including equivalents thereof.

›Tables in the description — 4
TABLE 1
CMP.NOR12R13R15R16R22R23R24R25R26R3R4R5m/e
1ClHHCl(CH═CH)2HHHCNSCF3NH2478
2ClHHClHHHHHCNSCF3NH2428
3ClHHClMeHHHHCNSCF3NH2442
4ClHHClHNH2HHHCNSCF3NH2443
5ClHHClHNO2HHHCNSCF3NH2473
6ClHHClHNHAcHHHCNSCF3NH2485
7ClHHClHCHOHHHCNSCF3NH2456
8ClHHClHHOMeHHCNSCF3NH2458
9ClHHClHHSMeHHCNSCF3NH2474
10ClHHClHHFHHCNSCF3NH2446
11ClHHClHFHHHCNSCF3NH2446
12ClHHClHClFHHCNSCF3NH2480
13ClHHClHHClHHCNSCF3NH2462
14ClHHClHHBrHHCNSCF3NH2506
15ClHHClHClHClHCNSCF3NH2496
16ClHHClHHCF3HHCNSCF3NH2496
17ClHHClHCF3HCF3HCNSCF3NH2564
18ClHHCl(CH═CH)2HHHCNSMeNH2424
19ClHHClHHHHHCNSMeNH2374
20ClHHClMeHHHHCNSMeNH2388
21ClHHClHNH2HHHCNSMeNH2389
22ClHHClHNO2HHHCNSMeNH2419
23ClHHClHNHAcHHHCNSMeNH2431
24ClHHClHHCHOHHCNSMeNH2402
25ClHHClHHOMeHHCNSMeNH2404
26ClHHClHFHHHCNSMeNH2392
27ClHHClHClFHHCNSMeNH2426
28ClHHClClHClHHCNSMeNH2442
29ClHHClHHCF3HHCNSMeNH2442
30ClHHClHCF3HCF3HCNSMeNH2510
31ClHHClHBrHHHCNSMeNH2452
32ClHHClMeHHHHCNSCF3Van-CH═N—576
33ClHHClHNO2HHHCNSCF3Van-CH═N—607
34ClHHClHNHAcHHHCNSCF3Van-CH═N—619
35ClHHClHHCHOHHCNSCF3Van-CH═N—590
36ClHHClHHOMeHHCNSCF3Van-CH═N—592
37ClHHClHClFHHCNSCF3Van-CH═N—614
38ClHHClClHClHHCNSCF3Van-CH═N—630
39ClHHClHHCF3HHCNSCF3Van-CH═N—630
40ClHHClHHCF3HHCNS(O)2CCl2FNH2560
41ClHHClHHCF3HHCNS(O)2CCl2FNH2544
42ClHHClHHCF3HHCNSCCl2FNH2528
43ClHHClHHCF3HHCNSOCF3NH2512
44ClHHClHHCF3HHCNS(O)2CF3NH2528
45ClHHClHHCF3HHPhC(O)SCF3NH2575
46ClHHCl(CH═CH)2HHHCNSCF3H463
47ClHHClH(CH═CH)2HHCNSCF3H463
48ClHHClHHHHHCNSCF3H413
49ClHHClHNO2HHHCNSCF3H458
50ClHHClHHOMeHHCNSCF3H443
51ClHHClHHSMeHHCNSCF3H459
52ClHHClHHFHHCNSCF3H431
53ClHHClHFHHHCNSCF3H431
54ClHHClHClFHHCNSCF3H465
55ClHHClHHClHHCNSCF3H447
56ClHHClHHBrHHCNSCF3H491
57ClHHClHClHClHCNSCF3H481
58ClHHClClHClHHCNSCF3H481
59ClHHClHHCF3HHCNSCF3H481
60ClHHClHCF3HHHCNSCF3H481
61ClHHClHCF3HCF3HCNSCF3H549
62ClHHClHClHHHCNSCF3H447
63ClHHClHBrHHHCNSCF3H491
64ClHHClHHCF3HHPhC(O)S(O)2CCl2FNH2639
65ClHHClHHBrHHCNSCCl2FNH2538
66ClHHClClHCF3HClCNSCF3NH2564
67ClHHClHHOCF3HHCNSCF3NH2512
68ClHHClHHCF3HHPhC(O)S(O)2CClF2NH2623
69ClHHClHHCF3HHCNHNH2396
70ClHHClHHCF3HHCNBrNH2474
71ClHHClHHCF3HHCNSEtNH2456
72ClHHClHHCF3HHCNSMeNH2442
73ClHHClHHCF3HHCNSCNNH2453
74ClHHClHHCF3HHCNClNH2430
75ClHHClHHCF3HHCNSOMeNH2458
76ClHHClHHCF3HHCNS(O)EtNH2472
77ClHHClHHBrHHCNS(O)2CCl2FNH2570
78ClHHClHHCF3HHCNS(O)2CH3NH2474
79ClHHClHHCF3HHCNS(O)2EtNH2488
80ClHHClHHCF3HHCONH2C(OH)(CF3)2NH2580
81ClHHClHHCF3HHCNC(OH)(CF3)2NH2562
82ClHHClHHCF3HHCNHNHAc438
83ClHHClHHCF3HHAcSMeNH2459
84ClHHClHHCF3HHCNCF(CF3)2NH2564
85ClHHClHHCF3HHCNSCCl2FH513
86ClHHClHHCF3HHCNS(O)2CCl2FH545
87ClHHClHClClHHCNHNH2396
88ClHHClHHOCF3HHCNHNH2412
89ClHHClFHHHHCNHNH2346
90ClHHClHHCO2MeHHCNHNH2386
91ClHHClHClClHHCNSCF3NH2496
92ClHHClFHHHHCNSCF3NH2446
93ClHHClHHCO2MeHHCNSCF3NH2486
94ClHHClHHCF3HHCNSCCl2FBr591
95ClHHClHHCF3HHAcS(O)2CH3NH2491
96ClHHClClHHHClCNSCF3NH2496
97ClHHClClHClHHCNSCF3NH2496
98ClHHClClHCF3HClCNSCF3NH2564
99ClHHClCF3HHHHCNSCF3NH2496
100ClHHClNO2HCF3HHCNSCF3NH2541
101ClHHClMeHFHHCNSCF3NH2460
102ClHHClHFHFHCNSCF3NH2464
103ClHHClFHHHFCNSCF3NH2464
104ClHHClHOCF3HHHCNSCF3NH2512
105ClHHClHFHClHCNSCF3NH2480
106ClHHClHCNHHHCNSCF3NH2453
107ClHHClHOMeHHHCNSCF3NH2458
108ClHHClHHCH2CNHHCNSCF3NH2467
109ClHHClHHMsHHCNSCF3NH2506
110ClHHClHHSO2NH2HHCNSCF3NH2507
111ClHHClHHNMe2HHCNSCF3NH2471
112ClHHClOCH2OHHHCNSCF3NH2472
113ClHHClHHCNHHCNSCF3NH2453
114ClHHClHHCNHHCNSCF3NH2453
115ClHHClFHFHHCNSCF3NH2464
116ClHHClHHCONH2HHCNSCF3NH2471
117ClHHClHClCNHHCNSCF3NH2487
118ClHHClHCF3HHHCNSCF3NH2496
119ClHHClFFFFFCNSCF3NH2518
120ClHHClHHOPhHHCNSCF3NH2520
121ClHHClClHCF3HHCNSCF3NH2530
122ClHHClHOCF2OHHCNSCF3NH2508
123ClHHClHFNH2HHCNSCF3NH2461
124ClHHClHCF3NO2HHCNSCF3NH2541
125ClHHClOHHHHHCNSCF3NH2444
126ClHHClHHNH2HHCNSCF3NH2443
127ClHHClHHOHHHCNSCF3NH2444
128ClHHClHCF3HNH2NH2CNSCF3NH2526
129ClHHClHFMeHHCNSCF3NH2460
130ClHHClCNFHHHCNSCF3NH2471
131ClHHClHMeFHHCNSCF3NH2460
132ClHHClMeHHFHCNSCF3NH2460
133ClHHClPhHHHHCNSCF3NH2504
134ClHHClOHOMeHCHOHCNSCF3NH2502
135ClHHClHClClHHCNS(O)2CH3NH2474
136ClHHClClHHHClCNS(O)2CH3NH2474
137ClHHClClHClHHCNS(O)2CH3NH2474
138ClHHClClHCF3HClCNS(O)2CH3NH2542
139ClHHClHHOCF3HHCNS(O)2CH3NH2490
140ClHHClCF3HHHHCNS(O)2CH3NH2474
141ClHHClNO2HCF3HHCNS(O)2CH3NH2519
142ClHHClMeHFHHCNS(O)2CH3NH2438
143ClHHClHFHFHCNS(O)2CH3NH2442
144ClHHClFHHHFCNS(O)2CH3NH2442
145ClHHClFHHHHCNS(O)2CH3NH2424
146ClHHClHHCF3HHCNC═NOHNH2439
147ClHHClHHCF3HHCNNO2NHAc483
148ClHHClHHCF3HHCNNO2NH2441
149ClHHClFHFHHCNS(O)2CH3NH2442
150ClHHClHOCF3HHHCNS(O)2CH3NH2490
151ClHHClHFHClHCNS(O)2CH3NH2458
152ClHHClHHCONH2HHCNS(O)2CH3NH2449
153ClHHClHCNHHHCNS(O)2CH3NH2431
154ClHHClHHSMeHHCNS(O)2CH3NH2452
155ClHHClHOMeHHHCNS(O)2CH3NH2436
156ClHHClHHCH2CNHHCNS(O)2CH3NH2445
157ClHHClHHMsHHCNS(O)2CH3NH2484
158ClHHClHHSO2NH2HHCNS(O)2CH3NH2485
159ClHHClHHNMe2HHCNS(O)2CH3NH2449
160ClHHClOCH2OHHHCNS(O)2CH3NH2450
161ClHHClHClCNHHCNS(O)2CH3NH2465
162ClHHClHHCNHHCNS(O)2CH3NH2431
163ClHHClHHCO2MeHHCNS(O)2CH3NH2464
164ClHHClHCF3HHHCNS(O)2CH3NH2474
165ClHHClFFFFFCNS(O)2CH3NH2496
166ClHHClHHOPhHHCNS(O)2CH3NH2498
167ClHHClClHCF3HHCNS(O)2CH3NH2508
168ClHHClClHSF5HClCNS(O)2CH3NH2600
169ClHHClClHOCF3HClCNS(O)2CH3NH2558
170ClHHClHOCF2OHHCNS(O)2CH3NH2486
171ClHHClHCO2HOHHHCNS(O)2CH3NH2466
172ClHHClHFOHHHCNS(O)2CH3NH2440
173ClHHClHFNH2HHCNS(O)2CH3NH2439
174ClHHClHCF3NO2HHCNS(O)2CH3NH2519
TABLE 2
CMP.NOR12R13R15R16R2R22R23R24R25R26R3R4R5m/e
175ClHHClH(CH═CH)2HHHSCFC12CNCl528
176ClHHClClH(CH═CH)2HHCNSCFCl2H528
177ClHHClClHHHHHCNSCFCl2H478
178ClHHClHHHMeHHSCFCl2CNCl492
179ClHHClHMeHHHHSCFCl2CNCl492
180ClHHClClHNH2HHHCNSCFCl2H493
181ClHHClHHNO2HHHSCFCl2CNCl523
182ClHHClClHNHAcHHHCNSCFCl2H535
183ClHHClHCHOHHHHSCFCl2CNCl506
184ClHHClHHCHOHHHSCFCl2CNCl506
185ClHHClClHHCHOHHCNSCFCl2H506
186ClHHClHOMeHHHHSCFCl2CNCl508
187ClHHClHHOMeHHHSCFCl2CNCl508
188ClHHClClHHOMeHHCNSCFCl2H508
189ClHHClClHHSMeHHCNSCFCl2H524
190ClHHClHHHFHHSCFCl2CNCl496
191ClHHClClHFHHHCNSCFCl2H496
192ClHHClClHClFHHCNSCFCl2H530
193ClHHClHHHClHHSCFCl2CNCl512
194ClHHClHHHBrHHSCFCl2CNCl556
195ClHHClClHClHClHCNSCFCl2H546
196ClHHClHClHClHHSCFCl2CNCl546
197ClHHClClHHCF3HHCNSCFCl2H546
198ClHHClClHCF3HHHCNSCFCl2H546
199ClHHClHHCF3HCF3HSCFCl2CNCl614
200ClHHClClHClHHHCNSCFCl2H512
201ClHHClClHBrHHHCNSCFCl2H556
202ClHHClHHHCF3HHS(O)CFCl2CNCl562
203ClHHClHHHCF3HHS(O)2CFCl2CNCl578
204HHHHHHHCF3HHCHOHH315
205HHHMeHHHCF3HHCHOHH329
206MeHHMeHHHCF3HHCHOHH343
207ClHHHHHHCF3HHCHOHH349
208HClHHHHHCF3HHCHOHH349
209ClHHMeHHHCF3HHCHOHH363
210ClHHClHHHCF3HHCHOHH383
211FHHHHHHCF3HHCHOHH333
212FHHFHHHCF3HHCHOHH351
213HHHCF3HHHCF3HHCHOHH383
214HHCF3HHHHCF3HHCHOHH383
215FFFFHHHCF3HHCHOHH387
216MeHHNO2HHHCF3HHCHOHH374
217HH(CH═CH)2HHHCF3HHCHOHH365
TABLE 3
CMP.NOR12R13R15R16R22R23R24R25R26R3R5m/3
218ClHHClHHCF3HHt-BuNH2428
219ClHHClHHCF3HHt-BuH413
220ClHHClHHCF3HHt-BuBr491
221ClHHClHHCF3HHCF3NH2440
222ClHHClHNO2HHHCF3NH2417
223ClHHClHFHHHCF3NH2390
224ClHHClHHCF3HHCF3Br503
225ClHHClHHCF3HHCF3H425
226ClHHClH(CH═CH)2HHCF3NH2422
227ClHHCl(CH═CH)2HHHCF3NH2422
228ClHHClMeHHHHCF3NH2386
229ClHHClHOMeHHHCF3NH2402
230ClHHClHHOMeHHCF3NH2402
231ClHHClHHSMeHHCF3NH2418
232ClHHClHHFHHCF3NH2390
233ClHHClHHClHHCF3NH2406
234ClHHClHHBrHHCF3NH2450
235ClHHClHClHClHCF3NH2440
236ClHHClClHClHHCF3NH2440
237ClHHClHCF3HHHCF3NH2440
238ClHHClHClHHHCF3NH2406
239ClHHClHBrHHHCF3NH2450
240ClHHCl(CH═CH)2HHHCF3H407
241ClHHClHHHHHCF3H357
242ClHHClHHMeHHCF3H371
243ClHHClHNO2HHHCF3H402
244ClHHClHCHOHHHCF3H385
245ClHHClHOMeHHHCF3H387
246ClHHClHHFHHCF3H375
247ClHHClHHFHHCF3H375
248ClHHClHFHHHCF3H375
249ClHHClHClFHHCF3H409
250ClHHClH(CH═CH)2HHCF3H407
251ClHHClHNHAcHHHCF3H414
252ClHHClCHOHHHHCF3H385
253ClHHClHHCHOHHCF3H385
254ClHHClOMeHHHHCF3H387
255ClHHClHHCF3HHSMeH403
256ClHHClHHCF3HHSMeNH2418
257ClHHClHHCF3HHSOMeNH2434
258ClHHClHHCF3HHSOMeH419
259ClHHClHHCF3HHSOMeBr497
260ClHHClHHCF3HHSCCl2FH489
261ClHHClHHCF3HHS(O)CCl2FH505
263ClHHClHHCF3HHS(O)2CCl2FH521
TABLE 4
CMP.NOR12R13R15R16R21R23R24R25R26R4R5m/e
264ClHHClHHCF3HHSCCl 2 FH488
265ClHHClHHCF3HHSCCl 2 FBr566
266ClHHClHHCF3HHSCCl 2 FNH2503
267ClHHClHHCF3HHSO 2 CCl2FBr537
268ClHHClHHCF3HHSOCCl 2 FH504
269ClHHClHHCF3HHSO2CCl2FH520
270HHHFHHCF3HHSOCCl2FH454
271ClHHClClHCF3HClSOCCl2FH572
272ClHHClHHOCF3HHSOCCl2FH520
273ClHHClHOCF2OHHSOCCl2FH516
274ClHHClHHHHHSOCCl2FH436
275ClHHClMeHMeMeHSOCCl2FH478
276ClHHClMeHHHMeSOCCl2FH464
277ClHHClHHt-BuHHSOCCl2FH492
278ClHHClHCF3HCF3HSOCCl2FH572
279ClHHClHCH2CNHHHSOCCl2FH475
280ClHHClHOCH2OHHSOCCl2FH480
281ClHHClHFHFHSOCCl2FH472
282ClHHClFFNH2FFSOCCl2FH523
283ClHHClNO2HCF3HHSOCCl2FH549
284ClHHClHHCH2CNHHSOCCl2FH475
285ClHHClHHn-BuHHSOCCl2FH492
286ClHHClClHClHHSOCCl2FH504
287ClHHClHNO2NH2MeMeSOCCl2FH524
288ClHHClClHCF3HHSOCCl2FH538
289ClHHClClHClHClSOCCl2FH538
290ClHHClFFCF3FFSOCCl2FH576
291ClHHClFFCNFFSOCCl2FH533
292ClHHCl5-tetrazolylHHHHSOCCl2FH504
293ClHHClHHCNHHSOCCl2FH461
294ClHHClClHSF5HClSOCCl2FH630
295HHHFHHCF3HHSOCCl2FH438
296ClHHClHHCF3HHSCF3H456
297ClHHClHHCF3HHSOCF3H472
298ClHHClHHCF3HHSO 2 CF3H488

Claims as granted

40 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

30 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01N43/36
  • A01N43/653
  • A01N43/56
  • A01N47/02
  • A01N43/50
Section C — Chemistry; metallurgy
  • C07D231/40
  • C07D233/88
  • C07D249/08
  • C07D231/18
  • C07D249/14
  • C07D521/00
  • C07D249/12
  • C07D207/36
  • C07D405/10
  • C07D249/10
  • C07D231/44
  • C07D233/90
  • C07D231/38
  • C07D233/84
  • C07D403/10
  • C07D207/333
  • C07D207/32
USPC · US Patent Classification
514/340548/263.8514/384548/264.2546/272.4514/383548/265.6548/269.4

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomApr 2002Jul 2002Oct 2002Jan 2003Apr 2003Jul 2003Oct 2003USPTOApplicantRestriction requirementNon-final rejectionResponse after non-finalNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
1.2 y
453 days filing → grant
Office actions
1
after a restriction
Responses
1
no RCE
Examiner
Fiona T. Powers
art unit 1626 · TC 1600
Citations: 32 back · 4 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

No assignments have been recorded for this application yet.